Portfolio

Investments

View all

Epizyme, Inc.

Biopharmaceutical company that is creating innovative drugs for major diseases based on important discoveries emerging from the field of Epigenetics

Sector: Biopharmaceuticals, Healthcare
Company Status: Private
Investment Status: Current

Associated Team Members:
Sara Nayeem, MD
Robert Garland, MD

Board Members:
David Mott

Back to Previous